Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility.
Abdulrahman K S AyfanJoanne MacdonaldAdam David IrwinHosam M ZowawiBrian M FordeDavid L PatersonMonica M LahraDavid M WhileyPublished in: The Journal of antimicrobial chemotherapy (2022)
These proof-of-concept data show that RPA technology has considerable promise for detecting N. gonorrhoeae and associated antibiotic susceptibility and would offer a diagnostic-based stewardship strategy identified as urgently needed by the WHO.